Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

immunotherapy

  • You have access
    Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of 18F-FDG PET/CT
    Amir Iravani and Rodney J. Hicks
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 943-950; DOI: https://doi.org/10.2967/jnumed.119.234278
  • You have access
    Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
    Aiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent Dercle
    Journal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
  • Open Access
    An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
    Christian A. Mason, Susanne Kossatz, Lukas M. Carter, Giacomo Pirovano, Christian Brand, Navjot Guru, Carlos Pérez-Medina, Jason S. Lewis, Willem J.M. Mulder and Thomas Reiner
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 433-436; DOI: https://doi.org/10.2967/jnumed.119.230466
  • You have access
    The Immunoimaging Toolbox
    Aaron T. Mayer and Sanjiv S. Gambhir
    Journal of Nuclear Medicine August 1, 2018, 59 (8) 1174-1182; DOI: https://doi.org/10.2967/jnumed.116.185967
  • You have access
    Immune Modulation Therapy and Imaging: Workshop Report
    Anthony F. Shields, Paula M. Jacobs, Mario Sznol, Michael M. Graham, Ron N. Germain, Lawrence G. Lum, Elizabeth M. Jaffee, Elisabeth G.E. de Vries, Sridhar Nimmagadda, Annick D. Van den Abbeele, David K. Leung, Anna M. Wu, Elad Sharon and Lalitha K. Shankar
    Journal of Nuclear Medicine March 1, 2018, 59 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.117.195610
  • You have access
    CXCR4 Ligands: The Next Big Hit?
    Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
  • You have access
    Molecular Imaging of Immunotherapy Targets in Cancer
    Emily B. Ehlerding, Christopher G. England, Douglas G. McNeel and Weibo Cai
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1487-1492; DOI: https://doi.org/10.2967/jnumed.116.177493
  • You have access
    Molecular Imaging Reveals Trastuzumab-Induced Epidermal Growth Factor Receptor Downregulation In Vivo
    Teng Ma, Xianlei Sun, Liyang Cui, Liquan Gao, Yue Wu, Hao Liu, Zhaohui Zhu, Fan Wang and Zhaofei Liu
    Journal of Nuclear Medicine June 1, 2014, 55 (6) 1002-1007; DOI: https://doi.org/10.2967/jnumed.114.137000

Pages

  • Previous
  • 1
  • 2
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire